Multiplex Assay Kit for Apolipoprotein A4 (APOA4) ,etc. by FLIA (Flow Luminescence Immunoassay)

ApoA-IV; ApoAIV; Apo-A4

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Apolipoprotein A4 (APOA4) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Apolipoprotein A4 (APOA4) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Apolipoprotein A4 (APOA4) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Apolipoprotein A4 (APOA4) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 98-105 101
EDTA plasma(n=5) 78-91 82
heparin plasma(n=5) 83-98 94

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Apolipoprotein A4 (APOA4) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Apolipoprotein A4 (APOA4) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Apolipoprotein A4 (APOA4) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 94-105% 87-102% 84-98% 98-105%
EDTA plasma(n=5) 87-101% 87-104% 95-102% 79-94%
heparin plasma(n=5) 79-98% 83-99% 79-93% 82-101%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:APOA4) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Biochimica et Biophysica Acta Hepatic lipase- and endothelial lipase-deficiency in mice promotes macrophage-to-feces RCT and HDL antioxidant properties PubMed: 23328279
Exp Ther Med. Differential plasma proteome analysis in patients with high?altitude pulmonary edema at the acute and recovery phases Pubmed:24940404
EuPA Open Proteomics Human maternal plasma proteomic changes with parturition Sciencedirect:S2212968514000506
BJOG Development of concise audit standards for unplanned return to theate following gynaecological surgery at Gloucestershire Royal Hospital Doi: 10.1111
Diagnostics Systemic Alterations of Immune Response-Related Proteins during Glaucoma Development in the Murine Model DBA/2J Pubmed: 32585848
VETERINARY PATHOLOGY Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats Pubmed: 32880234
Cancer Cell Int Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer 33602229
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
APB967Hu02 Active Apolipoprotein A4 (APOA4) Cell culture; Activity Assays.
RPB967Hu02 Recombinant Apolipoprotein A4 (APOA4) Positive Control; Immunogen; SDS-PAGE; WB.
RPB967Hu01 Recombinant Apolipoprotein A4 (APOA4) Positive Control; Immunogen; SDS-PAGE; WB.
PAB967Hu01 Polyclonal Antibody to Apolipoprotein A4 (APOA4) WB,IHC
PAB967Hu02 Polyclonal Antibody to Apolipoprotein A4 (APOA4) WB,IHC
MAB967Hu22 Monoclonal Antibody to Apolipoprotein A4 (APOA4) WB; IHC; ICC; IP.
SEB967Hu ELISA Kit for Apolipoprotein A4 (APOA4) Enzyme-linked immunosorbent assay for Antigen Detection.
SCB967Hu CLIA Kit for Apolipoprotein A4 (APOA4) Chemiluminescent immunoassay for Antigen Detection.
LMB967Hu Multiplex Assay Kit for Apolipoprotein A4 (APOA4) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSB967Hu01 ELISA Kit DIY Materials for Apolipoprotein A4 (APOA4) Main materials for "Do It (ELISA Kit) Yourself".